Navigation Links
Big Pharma to Come Together at ChemOutsourcing 2013 in Long Branch, New Jersey, Sept 16-19
Date:9/12/2013

TEANECK, N.J., Sept. 12, 2013 /PRNewswire-iReach/ -- Legions of chemistry sourcing executives from the world's largest pharmaceutical companies will be gathering at Ocean Place Resort in Long Branch, NJ next week to attend the annual ChemOutsourcing show, reports Mark Alexay, the event organizer.

"This year's banner turnout of Big Pharma executives comes as a pleasant surprise", remarked Alexay in the days before the show. "The event is located in the epicenter of the pharmaceutical industry and their many suppliers will be at the show. Nearly 200 sourcing and procurement professionals from area companies like Bristol-Myers Squibb, Merck, Pfizer, and GlaxoSmithKline will be coming.  Midwest companies like Eli Lilly and AbbVie will be well represented, too."

Alexay went on to comment, "I think the recovering pharmaceutical economy has helped attendance this year. After 5 years of anemic funding of early stage biotech we are now seeing an uptick in investment.  This has helped finance new discovery research and today there now more compounds in clinical development. This has spurred business for the CRO's and CMO's that undergird the effort".

ChemOutsourcing, in its 7th year, will take place September 16-19, 2013.

Over 100 exhibitors of custom synthesis and related services will participate, as will 750 total attendees.  The show is centered in the exhibit halls during the day and at night, socializing events like the annual Beach Party and Casino Night provide a relaxed atmosphere for networking.  Attendees are from Big Pharma as well as from dozens of medium sized and '"Emeerging" pharmaceutical companies. The supplier base if contract research aand development is also in attendance. Delegates from about 30 countries in North America, Europe, India, and China.

For more information visit www.chemoutsourcing.com or info@chemoutsourcing.com

Media Contact: mark alexay, apaporis, llc, 201-452-4023, malexay@chemoutsourcing.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE ChemOutsourcing
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016  Nearly 30 million people ... from the epidemic of diabetes. 1 However, nearly ... elevated glucose levels (hyperglycemia) and significant glucose variability. 2 ... complications, including cardiovascular events. If left untreated, hyperglycemia can ... eye disease or blindness. 3 As ...
(Date:12/6/2016)... With opioids commonly used for pain management for workplace ... that has led to nationwide fatalities. The synthetic opioid ... than heroin or morphine, resulting in likelihood of addiction, abuse or ... , , ... operations, Behavioral Health for HMC HealthWorks, explained the opioid drug is ...
(Date:12/6/2016)... , Dec. 6, 2016  Blueprint Medicines Corporation ... and developing targeted kinase medicines for patients with genomically ... underwritten public offering of $125,000,000 million in shares of ... grant the underwriters a 30-day option to purchase up ... its common stock in connection with the public offering. ...
Breaking Medicine Technology:
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... City, CA (PRWEB) , ... December 07, 2016 , ... ... during the holidays and winter seasons. One major study analyzing heart attacks among ... compared to August of a given year. We would all agree of course–no time ...
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX ... media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes ... use drop zones. Editors can select from a variety of flip book animations. In ...
(Date:12/7/2016)... CINCINNATI, Ohio (PRWEB) , ... December 07, 2016 ... ... winner in the 2016 BOC Business Brilliance Awards under the Best New Product ... inception and results achieved through user experience. , BOC Global Events & Training ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... its newest portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare ... enhances the WellnessPro platform by expanding the treatment modalities available in a ...
Breaking Medicine News(10 mins):